Avantax Advisory Services Inc. Buys 192 Shares of Solventum Co. (NYSE:SOLV)

Avantax Advisory Services Inc. grew its position in Solventum Co. (NYSE:SOLV) by 2.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 8,835 shares of the company’s stock after acquiring an additional 192 shares during the period. Avantax Advisory Services Inc.’s holdings in Solventum were worth $584,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Modus Advisors LLC bought a new stake in Solventum in the fourth quarter valued at approximately $25,000. Stonebridge Financial Group LLC bought a new stake in shares of Solventum in the 4th quarter valued at $26,000. Crews Bank & Trust acquired a new stake in shares of Solventum during the fourth quarter worth $32,000. True Wealth Design LLC raised its stake in Solventum by 23,550.0% during the third quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after buying an additional 471 shares during the last quarter. Finally, Prospera Private Wealth LLC acquired a new position in Solventum in the third quarter valued at $35,000.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Bank of America increased their price target on Solventum from $80.00 to $85.00 and gave the stock a “neutral” rating in a report on Wednesday, February 26th. Piper Sandler increased their target price on shares of Solventum from $75.00 to $84.00 and gave the stock a “neutral” rating in a research note on Friday, February 28th. Mizuho lifted their price target on shares of Solventum from $70.00 to $82.00 and gave the company a “neutral” rating in a research note on Monday, March 3rd. The Goldman Sachs Group upped their price objective on shares of Solventum from $63.00 to $71.00 and gave the company a “sell” rating in a report on Monday, March 3rd. Finally, Morgan Stanley raised their target price on Solventum from $73.00 to $80.00 and gave the company an “equal weight” rating in a research note on Wednesday, March 5th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $79.86.

Solventum Trading Down 1.3 %

Shares of SOLV stock opened at $74.00 on Friday. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The firm has a market cap of $12.80 billion and a P/E ratio of 26.91. The company has a 50 day moving average of $75.17 and a 200-day moving average of $71.56. Solventum Co. has a 12-month low of $47.16 and a 12-month high of $85.92.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.